LOTUS REPORTS ITS BEST QUARTER EVER WITH THE BIGGEST LAUNCH IN ITS HISTORY
Lotus Pharmaceutical (1795: TT), a multinational pharmaceutical company, today reported its financial results for the third quarter ended 30 September 2022. Third quarter financial highlights: Third quarter 2022 is the best quarter ever in the Company’s history, majorly driven by the successful launch of Lenalidomide in the US – the biggest launch in Lotus history […]
